• Digoxin: From Pump Inhibition to Assay Design

  2026-09-01

  Digoxin is a Na+/K+ ATPase pump inhibitor whose effects connect ion transport, cardiac contractility modulation, and cell-type-specific antiviral phenotypes. This guide translates its mechanism and product characteristics into a rigorous framework for cardiac and chikungunya research assay design.

• Biotin Azide for Click-Labeling Workflows

  2026-08-31

  Biotin Azide converts terminal-alkyne biomolecules into affinity-ready probes for detection, enrichment, and interaction studies. This practical guide connects CuAAC workflow design with the Frizzled5–cholesterol–Wnt signaling question while clearly separating validated product facts from optimization starting points.

• Standardized Whole-Blood Stimulation in Immunometabolism

  2026-08-31

  Zhao and colleagues present a standardized fresh whole-blood stimulation protocol for testing how metabolic interventions shape cytokine responses to pattern-recognition and microbial stimuli. Its main contribution is a reproducible bridge between immune activation and metabolism that can support cohort studies and mechanistic assay development, while remaining distinct from direct evidence of clinical or tumor-model efficacy.

• Mitomycin C: Translational Logic Beyond DNA Damage

  2026-08-30

  Mitomycin C is more than a DNA synthesis inhibitor: it is a mechanistically defined stressor for testing replication failure, apoptosis sensitization, and biomarker-guided combination strategies. This article connects its oncology applications with emerging tRF16–ALKBH5–NFKBIA biology while clearly separating evidence from hypothesis.

• Rotigotine for Parkinson’s Disease Research

  2026-08-29

  Rotigotine combines D2/D3 receptor activation with a practical model toolkit spanning neuroprotection, motor dysfunction, and depression-like phenotypes. This workflow-centered guide shows how to select doses, separate antidepressant-like activity from locomotor stimulation, and troubleshoot cell and animal assays.

• Carbapenemase Gene Transmission in CREC

  2026-08-29

  Chen and colleagues mapped carbapenemase-encoding genes, their chromosomal or plasmid locations, transferability, and strain relatedness in carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong. The study shows that plasmid-associated blaNDM-1 and mobile genetic elements support substantial horizontal dissemination alongside multidrug resistance, while genotyping indicates both broad diversification and possible clonal spread.

• Anagliptin (SK-0403) Vascular Research Workflow

  2026-08-28

  Anagliptin (SK-0403) supports a two-tier workflow that connects DPP-4 target engagement with vascular smooth-muscle physiology. Its value extends beyond glycemic-control models into mechanistic assays of Kv channel modulation and SERCA pump regulation.

• Stat3–NF-κB Synergy in Fyn Neurodegeneration

  2026-08-28

  The 2024 reference study establishes a neural-specific zebrafish model showing that constitutively active Fyn drives dopaminergic neuron loss, mitochondrial aggregation, and microglial inflammation. Transcriptomic and chemical-inhibition experiments identify Stat3 as a downstream Fyn effector that cooperates with NF-κB, providing a mechanistic framework for studying neuroinflammatory neurodegeneration.

• mCherry mRNA for LNP Delivery Assays

  2026-08-27

  EZ Cap™ mCherry mRNA combines Cap 1 capping, 5mCTP and ψUTP modification, and an optimized poly(A) tail for reproducible red reporter expression. It is especially useful for benchmarking lipid nanoparticle delivery, cell localization, and transfection quality before advancing to harder-to-measure therapeutic mRNA or gene-editing payloads.

• Rotigotine Hydrochloride in PD Research

  2026-08-27

  Build reproducible dopaminergic assays with Rotigotine hydrochloride, from SH-SY5Y neuroprotection and cytotoxicity screens to 6-OHDA or MPTP Parkinson’s disease models. Its receptor breadth and translational connection to continuous transdermal delivery make it useful for linking pathway activation with motor, inflammatory, and oxidative-stress readouts.

• Veratridine: A Causal Assay Framework

  2026-08-26

  Veratridine is a voltage-gated sodium channel opener that converts channel gating into a controllable model of depolarization, calcium stress, and excitotoxic injury. This article develops a causal assay framework that distinguishes sodium-channel effects from downstream glutamate and calcium mechanisms.

• Rotigotine Hydrochloride: A Translational Roadmap

  2026-08-26

  A thought-leadership guide to using Rotigotine hydrochloride as a dopamine D2/D3 receptor agonist in Parkinson’s disease research, depression models, and translational dopaminergic signaling studies, with emphasis on receptor breadth, behavioral confounding, delivery strategy, and reproducible experimental design.

• PFOS Injury in HK-2 Cells: Ferroptosis and ER Stress

  2026-08-25

  A 2025 study shows that perfluorooctane sulfonate damages human proximal tubular HK-2 cells alongside ferroptosis-associated iron and lipid peroxidation changes and activation of the endoplasmic reticulum stress response. Its value lies in connecting renal tubular injury with two interacting stress systems, while also defining practical readouts for follow-up mechanistic studies.

• Gallein B7271 for Reliable GPCR Assays

  2026-08-25

  This scenario-driven guide explains how Gallein (SKU B7271), a G protein βγ subunit inhibitor, can be integrated into cell signaling, viability, proliferation, macrophage, and cancer research workflows. It emphasizes solvent controls, model-specific dosing, orthogonal readouts, and practical product-selection criteria supported by formulation and quality-control data.

• Rotigotine Antidepressant Effects in Depression Models

  2026-08-24

  This 2006 study evaluated rotigotine across complementary rat models of anxiety, behavioral despair, learned helplessness, and depression-like hyperactivity. Its main contribution was showing antidepressant-like effects at lower doses while identifying locomotor activation at higher exposure as an important behavioral confound.

451 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page